Node Status
Learning Objectives
Learn about Shorter oral Bedaquiline-containing MDR/RR-TB regimen
Sub Nodes
- Shorter oral Bedaquiline-containing MDR/RR-TB regimen: Evidence
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Eligibility Criteria
- Eligibility Criteria for the Use of Bedaquiline [Bdq] in MDR/RR-TB Treatment​
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Pre-treatment Evaluation [PTE]
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Dosage of Drugs for Adults
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Drug Dose Administration
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Replacement Sequence of Drugs
- Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Treatment Extension
- Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Special Situations
- Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Pre-existing Liver Disease
- Possible Adverse Events Due to Drugs in Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
- Follow-up Evaluation of Patients on Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
- Follow-up monitoring of modified shorter oral MDR/RR-TB regimen with Lzd
- Regimen Modification of Shorter Oral MDR/RR regimen containing Bdq and Lnz